NCT01340326View on ClinicalTrials.gov

The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling

PHASE4CompletedINTERVENTIONAL

Enrollment

800

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Myocardial Infarction

Interventions

DRUG

high dose of valsartan

comparison of different dosages of drug

DRUG

usual dose of valsartan

comparison of different dosages of drug

Trial Locations (1)

Unknown

Department of Internal Medicine,Dong-A University College of Medicine, Busan

All Listed Sponsors

lead

Dong-A University

OTHER

NCT01340326 - The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling | Biotech Hunter | Biotech Hunter